News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK)'s Pioneering Bird Flu Vaccine Gets FFA Sciences Approval


11/25/2013 7:47:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Food and Drug Administration or FDA, Friday said it approved GlaxoSmithKline Plc's (GSK: Quote,GSK.L), first adjuvanted Influenza A (H5N1) Virus Monovalent Vaccine, for the prevention of H5N1 influenza. The vaccine is not intended for commercial use, and has been purchased by the U.S. Department of Health and Human Services from its maker, ID Biomedical Corporation of Quebec, an unit of GlaxoSmithKline Biologicals. This purchase would add the vaccine within the National Stockpile for distribution by public health officials if needed.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES